ICU MedicalICUI -2.23%80 EV-to-FCF is 65.27 as of Jul. 08, 2026, which is 68% above its 10-year median of 38.80. GuruFocus rates ICUI with a GF Score™ of 80/100 and a GF Value™ of $120.31 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 416 Medical Devices & Instruments companies, ICU Medical ranks worse than 81.73% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ICU Medical's Enterprise Value is $4,834 Mil.
ICU Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $74 Mil. Therefore, ICU Medical's EV-to-FCF for today is 65.27.
The historical rank and industry rank for ICU Medical's EV-to-FCF or its related term are showing as below:
ICUI'
s EV-to-FCF Range Over the Past 10 Years
Min: -5292.64 Med: 38.8 Max: 3918.94
Current: 65.27
During the past 13 years, the highest EV-to-FCF of ICU Medical was 3918.94. The lowest was -5292.64. And the median was 38.80.
ICUI's EV-to-FCF is ranked worse than 81.73% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.515
vs ICUI: 65.27
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ICU Medical's PE Ratio (TTM) for today is calculated as:
ICU Medical's share price for today is $151.73.
ICU Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.850.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
ICU Medical EV-to-FCF Related Terms
ICU Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for ICU Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ICU Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where ICU Medical's EV-to-FCF falls into.
ICU Medical's current Enterprise Value is $4,834 Mil.
ICU Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $74 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (ICUI) has a EV-to-FCF of 65.27 as of Jul. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ICU Medical and its competitors. This is 68% above median its historical median of 38.80. According to the industry distribution chart, ICU Medical ranks #340 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 81.7%.
Is ICU Medical's EV-to-FCF too high?
ICU Medical's current EV-to-FCF of 65.27 is 68% above median its 10-year median of 38.80. The Medical Devices & Instruments industry median EV-to-FCF is 23.52. ICU Medical's value of 65.27 is 177.6% above this industry median. Based on the distribution chart, ICU Medical ranks #340 out of 416 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, ICU Medical has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's EV-to-FCF compare to WRBY and MMED?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #340 out of 416 companies for EV-to-FCF. This places ICU Medical in the lower half of its industry. The industry median EV-to-FCF is 23.52. ICU Medical's value of 65.27 is 177.6% above this benchmark. While the company's 10-year median is 38.80 vs. the industry median of 23.52, ICU Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.52, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current EV-to-FCF of 65.27 is 177.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current EV-to-FCF is 65.27, which is 68% above median its own 10-year median of 38.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (ICUI) is currently considered Modestly Overvalued. The stock's GF Value™ is $120.31, compared to a current price of $151.73 — trading 26.1% above its estimated fair value. The current EV-to-FCF is 65.27, which is 68% above median its 10-year median of 38.80 and 177.6% above the Medical Devices & Instruments industry median of 23.52. ICU Medical's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For ICU Medical (ICUI), the current EV-to-FCF is 65.27 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (ICUI) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of $151.73 is trading 26.1% above its estimated GF Value™ of $120.31.
GuruFocus considers ICU Medical to be Modestly Overvalued.
Key valuation signals for ICUI:
EV-to-FCF: 65.27 (68% above median its 10-year median of 38.80)
GF Value™: $120.31 vs. price of $151.73 (26.1% above fair value)
Industry Position: 177.6% above the Medical Devices & Instruments median (#340 of 416)
No single metric tells the full story. See the ICUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
80GF Score
Get the complete analysis for ICUI
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ICUI has been successfully added to your 
